Table 1 Baseline characteristics of the 18 patients with CEP at diagnosis
Variable | Value* | Number reported/tested |
|---|---|---|
Age (years) | 56 (41–68) | 18 |
Disease duration (months) | 19.1 (9.9–28.7) | 18 |
Gender | 18 | |
Female | 8 (44.4) | |
Male | 10 (55.6) | |
Smoking status | 18 | |
Current smoker | 1 (5.6) | |
Ex-smoker | 4 (22.2) | |
Pack-year history | 25 (20–40) | |
Symptoms or signs | 18 | |
Cough | 15 (83.3) | |
Sputum | 13 (72.2) | |
Dyspnea | 5 (27.8) | |
Fever | 2 (11.1) | |
Wheezing | 4 (22.2) | |
Crackle | 3 (16.7) | |
History of tuberculosis | 1 (5.6) | 18 |
Laboratory findings | ||
White blood count (cells/μL) | 8060 (7470–9660) | 18 |
Peripheral eosinophil percentage (%) | 21.2 (11.6–42.3) | 18 |
Peripheral eosinophil count (cells/μL) | 1543 (771–4034) | 18 |
Eosinophil percentage in BAL fluid (%) | 47 (15–65) | 7 |
C-reactive protein (mg/dL) | 1.5 (0.30–3.27) | 15 |
Aspartate aminotransferase (IU/L) | 21 (17–24) | 17 |
Alanine aminotransferase (IU/L) | 17 (12–24) | 17 |
Blood urea nitrogen (mg/dL) | 10 (8–11) | 17 |
Creatinine (mg/dL) | 0.84 (0.66–0.98) | 17 |
Spirometric results | ||
Forced expiratory volume in 1 s/forced vital capacity ratio | 76.0 (62–82) | 15 |
% predicted forced expiratory volume in 1 s | 87.0 (67–100) | 15 |
% predicted forced vital capacity | 86.0 (72–97) | 15 |